{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:08:25Z","timestamp":1791216505876,"version":"4.1.0"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2017,9,25]],"date-time":"2017-09-25T00:00:00Z","timestamp":1506297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0184739","type":"journal-article","created":{"date-parts":[[2017,9,25]],"date-time":"2017-09-25T13:29:22Z","timestamp":1506346162000},"page":"e0184739","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":34,"title":["Cryptogenic organizing pneumonia\u2014Results of treatment with clarithromycin versus corticosteroids\u2014Observational study"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2585-8594","authenticated-orcid":true,"given":"El\u017cbieta","family":"Radzikowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"Wiatr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Langfort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Bestry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Skoczylas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Szczepulska-W\u00f3jcik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariusz","family":"Gawryluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Rudzi\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Chorostowska-Wynimko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazimierz","family":"Roszkowski-\u015ali\u017c","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,9,25]]},"reference":[{"key":"ref1","first-page":"554","article-title":"Clinical spectrum of cryptogenic organizing pneumonia","volume":"46","author":"R Bellomo","year":"1991"},{"key":"ref2","first-page":"422","article-title":"Cryptogenic organizing pneumonia","volume":"28","author":"JF Cordier","year":"2006"},{"key":"ref3","first-page":"715","article-title":"Bronchiolitis obliterans organizing pneumonia. Clinical features and differential diagnosis","volume":"102","author":"T Izumi","year":"1992"},{"key":"ref4","first-page":"14","article-title":"BOOP in Europe","volume":"102","author":"U Costabel","year":"1992"},{"key":"ref5","first-page":"8","article-title":"Cryptogenic organizing pneumonitis. The North American experience","volume":"102","author":"TE King Jr","year":"1992"},{"key":"ref6","first-page":"193","article-title":"BOOP: an important cause of migratory pulmonary infiltrates?","volume":"8","author":"TE King Jr","year":"1995"},{"key":"ref7","first-page":"1323","article-title":"Organizing pneumonia. Features and prognosis of cryptogenic, secondary, and focal variants","volume":"157","author":"RH Lohr","year":"1997"},{"key":"ref8","first-page":"93","article-title":"Heterogeneity of bronchiolitis obliterans organizing pneumonia","volume":"4","author":"GR Epler","year":"1998"},{"key":"ref9","first-page":"1929","article-title":"Bronchiolitis obliterans organizing pneumonia syndrome primed by radiation therapy to the breast. The Groupe d\u2019Etudes ET de Recherche sur les Maladies Orphelines Pulmonaries (GERM\u201dO\u201dP)","volume":"158","author":"B Crestani","year":"1998"},{"key":"ref10","first-page":"1599","article-title":"Factors related to the relapse of bronchiolitis obliterans organizing pneumonia","volume":"114","author":"K Watanabe","year":"1998"},{"key":"ref11","first-page":"702","article-title":"Bronchiolitis obliterans organizing pneumonia: an Italian experience","volume":"94","author":"S Cazzato","year":"2000"},{"key":"ref12","first-page":"571","article-title":"Cryptogenic organizing pneumonia. Characteristics of relapses in series of 48 patients","volume":"162","author":"R Lazor","year":"2000"},{"key":"ref13","first-page":"493","article-title":"Organizing pneumonia\u2014own experiences with clarithromycin treatment","volume":"72","author":"E Radzikowska","year":"2004"},{"key":"ref14","first-page":"254","article-title":"Bronchiolitis obliterans organizing pneumonia. Clinical and roentgenological features in 26 cases","volume":"72","author":"FS Oymak","year":"2005"},{"key":"ref15","first-page":"422","article-title":"Differences in treatment and in outcomes between idiopathic and secondary forms of organizing pneumonia","volume":"14","author":"KR Basarakodu","year":"2007"},{"key":"ref16","first-page":"689","article-title":"Clinical features in secondary and cryptogenic organizing pneumonia","volume":"11","author":"OA Sveinsson","year":"2007"},{"key":"ref17","first-page":"893","article-title":"Cryptogenic organizing pneumonia. Clinical presentation, radiographic findings, treatment response and prognosis","volume":"139","author":"F Drakopanagiotakis","year":"2011"},{"key":"ref18","first-page":"932","article-title":"Comparison between cryptogenic organizing pneumonia and connective tissue disease-related organizing pneumonia","volume":"50","author":"J-W Yoo","year":"2011"},{"key":"ref19","first-page":"1670","article-title":"Rapidly progressive bronchiolitis obliterans with organizing pneumonia","volume":"149","author":"AJ Cohen","year":"1994"},{"key":"ref20","first-page":"119","article-title":"Gastroesophageal reflux disease is a risk factor for severity of organizing pneumonia","volume":"89","author":"G Gaillet","year":"2015"},{"key":"ref21","first-page":"829","article-title":"Macrolide therapy in cryptogenic organizing pneumonia: A case report and review","volume":"9","author":"Q-L Ding","year":"2015"},{"key":"ref22","first-page":"65","article-title":"Long-dose\/long-term erythromycin for treatment of bronchiolitis obliterans organizing pneumonia (BOOP)","volume":"40","author":"Y Ichikawa","year":"1993"},{"key":"ref23","first-page":"152","article-title":"Bronchiolitis obliterans organizing pneumonia","volume":"312","author":"GR Epler","year":"1985"},{"key":"ref24","first-page":"3611","article-title":"Macrolides. A treatment alternative for bronchiolitis obliterans organizing pneumonia?","volume":"128","author":"DE Stover","year":"2005"},{"key":"ref25","first-page":"334","article-title":"Organizing pneumonia\u2014clarithromycin treatment","volume":"76","author":"E Radzikowska","year":"2008"},{"key":"ref26","first-page":"87","article-title":"Macrolide use leads to clinical and radiological improvement in patients with cryptogenic organizing pneumonia","volume":"11","author":"V Pathak","year":"2014"},{"key":"ref27","first-page":"590","article-title":"Mechanisms of action and clinical application of macrolides as immunomodulatory medications","volume":"23","author":"S Kanoh","year":"2010"},{"key":"ref28","first-page":"116","article-title":"Erythromycin treatment in diffuse panbronchiolitis","volume":"4","author":"S Kudoh","year":"1998"},{"key":"ref29","first-page":"CD002203","article-title":"Macrolide antibiotics for cystic fibrosis","volume":"11","author":"KW Southern","year":"2012"},{"key":"ref30","first-page":"594","article-title":"Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma","volume":"84","author":"H Amayasu","year":"2000"},{"key":"ref31","first-page":"361","article-title":"A pilot study of low dose erythromycin in bronchiectasis","volume":"13","author":"KW Tsang","year":"1999"},{"key":"ref32","first-page":"442","article-title":"A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation","volume":"70","author":"PA Corris","year":"2015"},{"key":"ref33","first-page":"461","article-title":"Increased macrophage inflammatory protein-1alpha and -1beta in BAL fluid of bronchiolitis obliterans organizing pneumonia","volume":"8","author":"T Asano","year":"2003"},{"key":"ref34","first-page":"44","article-title":"Clarithromycin inhibits NF-kappaB activation in human peripheral blood mononuclear cells and pulmonary epithelial cells","volume":"45","author":"T Ichiyama","year":"2001"},{"key":"ref35","first-page":"100","article-title":"Cryptogenic organizing pneumonia: increased expression of interleukin 8 and fibronectin genes by alveolar macrophages","volume":"10","author":"C Carre","year":"1994"},{"key":"ref36","first-page":"930","article-title":"Macrolides inhibit cytokine production by alveolar macrophages in bronchiolitis obliterans organizing pneumonia","volume":"218","author":"M Cai","year":"2013"},{"key":"ref37","first-page":"572","article-title":"Four cases of bronchiolitis obliterans organizing pneumonia associated thyroid disease","volume":"67","author":"K Watanabe","year":"2000"},{"key":"ref38","first-page":"1053","article-title":"Bronchiolitis obliterans with organizing pneumonia versus chronic eosinophilic pneumonia: high-resolution CT findings in 81 patients","volume":"176","author":"H Arakawa","year":"2001"},{"key":"ref39","first-page":"2513","article-title":"The diagnostic value of bronchoalveolar lavage and transbronchial biopsy in cryptogenic organizing pneumonia","volume":"9","author":"V Poletti","year":"1996"},{"key":"ref40","first-page":"77","article-title":"Cryptogenic Organizing Pneumonia: IL-1\u03b2. IL-6. IL-8. and TGF- \u03b21 Serum Concentrations and Response to Clarithromycin Treatment","volume":"911","author":"E Radzikowska","year":"2016"},{"key":"ref41","first-page":"871","article-title":"Clarithromycin decreases IL-6 concentration in serum and BAL fluid in patients with cryptogenic organizing pneumonia","volume":"25","author":"E Radzikowska","year":"2016"},{"key":"ref42","first-page":"566","article-title":"Risk of cardiac arrhythmia and mortality among patients using new-generation, macrolides fluoroquinolones, and \u03b2-lactam\/\u03b2-lactamase inhibitors: A Taiwanese Nationwide Study","volume":"60","author":"HW Chou","year":"2015"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0184739","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T10:31:18Z","timestamp":1540031478000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0184739"}},"subtitle":[],"editor":[{"given":"Antje","family":"Prasse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,9,25]]},"references-count":42,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2017,9,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0184739","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,25]]}}}